1. Home
  2. ZLAB vs VSAT Comparison

ZLAB vs VSAT Comparison

Compare ZLAB & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$25.10

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$73.65

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
VSAT
Founded
2013
1986
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
9.6B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
ZLAB
VSAT
Price
$25.10
$73.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$49.60
★ $59.80
AVG Volume (30 Days)
766.5K
★ 1.5M
Earning Date
05-07-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
38.46
★ 94.42
EPS
★ N/A
N/A
Revenue
★ $460,156,000.00
N/A
Revenue This Year
$9.75
$5.32
Revenue Next Year
$26.03
$3.57
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 15.33
N/A
52 Week Low
$15.96
$26.10
52 Week High
$34.72
$93.03

Technical Indicators

Market Signals
Indicator
ZLAB
VSAT
Relative Strength Index (RSI) 49.96 49.49
Support Level $24.81 $67.16
Resistance Level $25.28 $75.57
Average True Range (ATR) 0.77 3.91
MACD -0.14 0.28
Stochastic Oscillator 41.43 48.62

Price Performance

Historical Comparison
ZLAB
VSAT

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About VSAT ViaSat Inc.

Viasat Inc an world-wide provider of communications technologies and services, focused on making connectivity accessible, available and secure for current and future customers world-wide. The company has two reportable segments: communication services and defense and advanced technologies. It generates majority of revenue from communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers. It has presence in United States and Outside United States. The company generates majority of revenue from United States. Its products are Antennas, Terminals & radios, Modems, Semiconductors, Cybersecurity, Software & services, Home internet.

Share on Social Networks: